Dare acquiring Pear Tree

Daré BioScience Inc. (NASDAQ:DARE) will acquire Pear Tree Pharmaceuticals Inc. (Cambridge, Mass.), gaining its PT-101. The vaginal formulation of tamoxifen is being developed to treat vulvovaginal atrophy in breast cancer patients. Daré said the candidate has been evaluated in four subjects...